Key Highlights

  • Nvidia (NASDAQ:NVDA) is about 8% of the S&P 500's value, so its 3% swings, seen 30 times this year, move the whole index.
  • TSMC alone represents over 40% of Taiwan's TAIEX after regulators dropped a 20-year-old 30% single-stock cap for index-tracking funds.
  • South Korea's KOSPI behaves like just 11 firms beyond Samsung and SK Hynix, whose combined weight briefly topped 40% in June.
  • Switzerland's SPI shows concentration and Volatility aren't always linked, since its top five firms span varied, stable industries.

Concentration Has Quietly Reshaped What Benchmark Indices Measure

Major stock indices are increasingly reflecting the fortunes of a small group of corporate giants rather than the broader universe of domestic equities, and those giants are largely rising and falling with sentiment toward artificial intelligence investment. In the S&P 500, Nvidia (NASDAQ:NVDA) represents approximately 8% of total index value. A 3% share price move, which has happened roughly 30 times this year, would shift the entire 500-stock index by about a quarter of a percentage point even if every other constituent stayed flat, a larger single-stock impact than any company has had on the index historically.

The effect is magnified elsewhere in Asia. Taiwan Semiconductor Manufacturing Company, which produces Nvidia's AI processors, has seen its market Capitalization double to roughly $2 trillion over the past year and now accounts for more than 40% of the TAIEX index. Taiwanese regulators dropped a rule capping any single stock at 30% of an index-tracking fund's Assets last year specifically to let investors participate in TSMC's gains, leaving the more than 1,000-stock TAIEX behaving, by some measures, like an equal-weighted index of only about six companies.

South Korea's KOSPI Has Grown More Volatile as Chipmakers Dominate

A similar dynamic is playing out in South Korea, where the 830-company KOSPI index behaves as though it contains only 11 firms beyond Samsung Electronics and SK Hynix, the country's two dominant memory-chip makers. Their combined index weight briefly exceeded 40% in June, up from roughly a quarter in preceding years. The popularity of leveraged Exchange-traded funds among South Korean retail investors, which use borrowed money to amplify both gains and losses, has added to the index's volatility.

Between May and July, as global markets repeatedly repriced expectations for AI-related capital spending including memory chip demand, KOSPI volatility ran at roughly four times its average level over the prior year. The index moved by 5% or more once every three trading sessions on average, falling 11% in a single day on July 28 before rising 18% three days later. The Korea Exchange suspended trading five times in the first six months of the year and imposed trading curbs on nearly 30 other occasions, exceeding the total seen during the 2008 global financial crisis.

Not All Concentration Produces the Same Volatility

Concentration alone does not automatically translate into instability, as Switzerland's broad SPI index demonstrates. Nearly half the index's value sits in five companies, Roche, Novartis, Nestlé, ABB and UBS, but those firms span pharmaceuticals, food and beverages, industrial machinery, and banking, sectors that are broadly representative of the Swiss economy overall. Roughly one in two publicly listed Swiss companies operates in drugs, food and drink, machinery, or lending, compared with about one in six listed Taiwanese firms and one in 200 listed South Korean firms operating in chips or technology hardware.

The composition of the top Swiss stocks also matters. Firms such as Roche and Nestlé have stable Earnings and consistent Dividend payouts, making them structurally less volatile than technology shares whose valuations are tied closely to the outlook for AI infrastructure spending. Index dominance has also proven reversible in other cases: Novo Nordisk's rise to the top of Denmark's stock exchange, driven by Demand for its Ozempic weight-loss drug, gave way as Eli Lilly's competing treatment gained market share, reducing Novo Nordisk's index weight in turn.

Conclusion

The growing concentration of major indices in a small number of AI-linked companies means headline index performance increasingly diverges from the breadth of the underlying economy it is meant to represent, a dynamic that is likely to persist as long as Capital Markets remain focused on the trajectory of AI infrastructure spending. Whether this concentration eases will depend on how durable the earnings growth of companies such as Nvidia, TSMC, Samsung and SK Hynix proves to be, as well as whether unlisted competitors currently excluded from benchmark indices continue to grow in scale outside public markets.